Clinicopathologic characteristics and therapeutic responses of Chinese patients with non-small cell lung cancer who harbor an anaplastic lymphoma kinase rearrangement

INTRODUCTION: The rearrangement of the anaplastic lymphoma kinase (ALK) gene accounts for approximately 1%–6% of lung adenocarcinoma cases and defines a molecular subgroup of tumors characterized by clinical sensitivity to ALK inhibitors such as crizotinib. This study aimed to identify the relations...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Chin J Cancer
Main Authors: Fu, Sha, Wang, Hai-Yun, Wang, Fang, Huang, Ma-Yan, Deng, Ling, Zhang, Xiao, Ye, Zu-Lu, Shao, Jian-Yong
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4593362/
https://ncbi.nlm.nih.gov/pubmed/26253541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-015-0032-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados